Patent details

1129720 Title: Gestabiliseerde granulocyten koloniestimulerende factor.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
1129720
WO Application Number:
Type:
European Patent Granted for NL
Status:
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Non-payment of the annual fee
Application number:
13015763
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
EP1129720;

Dates

Filing date:
21/02/2001
Grant date:
23/06/2004
EP Publication Date:
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
23/06/2004
EP B1 Publication Date:
23/06/2004
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
29/07/2004
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
20/02/2021
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
01/09/2007

Applicant/holder

From:
23/06/2004
 
 

 

Name:
Pfizer Products Inc.
Address:
Groton, Connecticut 06340, United States of America (US)

Domicile Holder

Name:
Dr. R. Jorritsma c.s.
From:
11/06/2004
Address:
N.V. Nederlandsch Octrooibureau, Postbus 29720, 2502 LS Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
Hay, Josephine Nanette, Pfizer Global Research
Address:
United States of America (US)

2

Name:
Williams, Kathleen Brimelow
Address:
United States of America (US)

Priority

Priority Patent Number:
185769 P
Priority Date:
29/02/2000
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K38/19; A61K47/02; A61K47/12; A61K47/20;

Publication

Bulletin

1

Bulletin Heading:
VE4
Journal edition number:
200711
Publication date:
01/11/2007
Description:
Vervallen Europese octrooien wegens niet betalen van een jaarcijns

2

Bulletin Heading:
PE2
Journal edition number:
200410
Publication date:
01/10/2004
Description:
Verleende Europese octrooien die hebben voldaan aan art. 29P (ROW 1910) of art. 52 (ROW 1995)

3

Bulletin Heading:
PE3
Journal edition number:
200410
Publication date:
01/10/2004
Description:
Verleende Europese octrooien uit PE2 in alfabetische volgorde van namen van octrooihouders

4

Bulletin Heading:
PE1
Journal edition number:
200408
Publication date:
02/08/2004
Description:
Verleende Europese octrooien in nummervolgorde

Terms/Procedural Changes

Description:
Termijn voor indienen vertaling Europees octrooi [EN]
Date:
23/09/2004

Correspondence

1

Sent On Date:
06/09/2007
Letter Type:
Vervalbrief [EN]
Reference:
To:
Pfizer Products Inc., Eastern Point Road, Groton, Connecticut 06340-5146, United States of America (US)

2

Received On Date:
29/07/2004
Letter Type:
Vertaling Europees octrooi [EN]
Reference:
---
From:
Dr. R. Jorritsma c.s., N.V. Nederlandsch Octrooibureau, Postbus 29720, 2502 LS Den Haag, Netherlands (NL)

3

Sent On Date:
23/06/2004
Letter Type:
Termijnbrief [EN]
Reference:
BULLETIN 0426
To:
-

4

Received On Date:
03/06/2004
Letter Type:
Voorlopige domiciliekeuze [EN]
Reference:
P215676EP/NL
From:
Dr. R. Jorritsma c.s., N.V. Nederlandsch Octrooibureau, Postbus 29720, 2502 LS Den Haag, Netherlands (NL)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
09/01/2006
Last Annual Fee Paid Number:
2
Payer:
Master Data Center, Simon & Schuster
Filing date Document type Document Description Number of pages File Type
29/07/2004 Incoming Correspondence Paper 1 PDF /3/9/4/0/5/0700050493/migrated-docs/13015763_1_incomingcorrespondencepaper20040729.pdf
29/07/2004 Description 17 PDF /3/9/4/0/5/0700050493/migrated-docs/13015763_2_description20040729.pdf
29/07/2004 Claims 2 PDF /3/9/4/0/5/0700050493/migrated-docs/13015763_3_claims20040729.pdf
03/06/2004 Incoming Correspondence Paper 1 PDF /3/9/4/0/5/0700050493/migrated-docs/13015763_0_incomingcorrespondencepaper20040603.pdf